Both MicCropHealth and BeCrop are built around microbiome-based detection platforms applied directly to agricultural contexts.
BIOME MAKERS SPAIN SL
Spanish agri-biotech SME developing microbiome-based diagnostic platforms for early detection of biological threats in crops and soil.
Their core work
Biome Makers is a Spanish agricultural biotech company that develops microbiome-based diagnostic platforms for farming. Their core product analyzes the microbial communities in soil and crops to detect biological threats — pathogens, imbalances, disease precursors — before they cause visible damage. They translate complex microbiome data into actionable intelligence that farmers and agronomists can use to make crop protection and soil management decisions. Their work sits at the intersection of microbiology, data science, and precision agriculture.
What they specialise in
The shared technical objective across both projects is identifying biological threats in agriculture before they cause crop damage.
BeCrop (SME Phase 2, €1.7M) is a full market-entry project, indicating a commercially mature diagnostic product rather than pure research.
The progression from SME Phase 1 feasibility (MicCropHealth, €50K) to SME Phase 2 scale-up (BeCrop, €1.7M) demonstrates a deliberate path from concept validation to commercial launch.
How they've shifted over time
Their H2020 trajectory follows the classic SME Instrument path: a Phase 1 feasibility study in 2018 (MicCropHealth, €50K) proved the concept of microbiome-based agricultural diagnostics, and a Phase 2 market development grant in 2020 (BeCrop, €1.7M) funded the transition to a commercial product. There is no keyword divergence between the two phases because both address the same core technology — the evolution is not topical but developmental, from research proof-of-concept to market-ready platform. By the end of their H2020 participation they were no longer a research team testing an idea, but a product company scaling a validated diagnostic tool.
Biome Makers is moving toward full commercial deployment of their microbiome platform, making them a more relevant partner for applied agriculture, food safety, and soil health initiatives than for early-stage research consortia.
How they like to work
Biome Makers operates as a standalone innovator rather than a consortium builder — both of their H2020 grants were through the SME Instrument, which is designed for individual companies and does not require multi-partner consortia. They have zero registered consortium partners across all projects, which means they are accustomed to running full projects independently rather than as part of a research network. For potential collaborators, this suggests they would bring strong product ownership and execution capability, but may be less experienced coordinating across institutional partners.
Biome Makers has no recorded consortium partnerships in H2020, a direct consequence of the SME Instrument funding model which funds companies directly without requiring partners. Their collaboration footprint is therefore entirely national or commercial rather than through formal EU research networks.
What sets them apart
Biome Makers is one of the few Spanish SMEs to have successfully completed both phases of the EU SME Instrument in the agricultural microbiome space, which signals genuine validation by independent EU evaluators at both concept and commercialization stages. Unlike university spin-offs or research institutes offering microbiome services, they are building a product company — their value to a consortium is not academic expertise but a deployable diagnostic tool and the commercial ambition to scale it. For a food safety, precision agriculture, or crop protection consortium, they bring the rare combination of biological depth and product-market readiness that research partners typically cannot offer.
Highlights from their portfolio
- BeCropWith €1.7M in EC funding under SME Phase 2, BeCrop represents one of the largest individual SME Instrument awards in Spanish agricultural biotech and signals a commercially validated microbiome diagnostic platform ready for market.
- MicCropHealthAs the Phase 1 feasibility predecessor to BeCrop, MicCropHealth demonstrates that Biome Makers passed rigorous EU evaluation for their core concept before receiving scale-up funding — a two-stage validation few SMEs achieve.